In accordance with the aforementioned findings, we discovered that COPS5 blocked the ubiquitination of MK2 and increased its stability in HCC cells, allowing HCC cells to escape ferroptosis, consequently enhancing sorafenib resistance. The gene discussed is MAPKAPK2; the disease is hepatocellular carcinoma.